PrakashVishnuMD

Oncology • Seattle, WA

Physician

Join to view full profile

Dr. Vishnu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Vishnu's full profile

Already have an account?

Office
825 Eastlake Ave E
Seattle, WA 98109
Phone+1 206-520-5000

Fax+1 206-965-4119

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2008 - 2011
Detroit Medical Center/Wayne State UniversityResidency, Internal Medicine, 2005 - 2008
Bangalore Medical CollegeClass of 2001

Certifications & Licensure

CO State Medical License 2023 - 2025
WA State Medical License 2011 - 2025
FL State Medical License 2008 - 2020
AK State Medical License 2015 - 2016
MI State Medical License 2005 - 2008
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification HealthSentry EHR, Cerner Corporation, 2013

Publications & Presentations

PubMed

5 citations
A machine-learning model for reducing misdiagnosis in heparin-induced thrombocytopenia: A prospective, multicenter, observational study.
Henning Nilius, Adam Cuker, Sigve Haug, Christos Nakas, Jan-Dirk Studt
Eclinicalmedicine. 2023-01-01
38 citations
Haematological manifestations of human immune deficiency virus infection
Prakash Vishnu, David M. Aboulafia
British Journal of Haematology. 2015-10-09
12 citations
B-cell acute lymphoblastic leukemia in an elderly man with plasma cell myeloma and long-term exposure to thalidomide and lenalidomide: a case report and literature review
Ryan B. Sinit, Dick G Hwang, Prakash Vishnu, Jess F. Peterson, David M. Aboulafia
BMC Cancer. 2019-11-27

Lectures

ASH Choosing Wisely® Campaign: 2018 ASH Choosing Wisely Champions
60th American Society of Hematology Annual Meeting - 12/3/2018
Identification of a Novel Heterozygous Mutation (c.2213T>G;p.Leu738Arg) in Platelet Glycoprotein ITGB3 gene in a Patient with Glanzmann’s Thrombasthenia
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

ASH Recognizes Choosing Wisely Champions, Scholar Award Winners, and MoreJanuary 1st, 2019